CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
53.68
2%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.19
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

LeMaitre Vascular Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 52.63
Open* 51.64
1-Year Change* 10.53%
Day's Range* 51.64 - 53.74
52 wk Range 43.69-68.67
Average Volume (10 days) 107.91K
Average Volume (3 months) 2.94M
Market Cap 1.19B
P/E Ratio 43.68
Shares Outstanding 22.26M
Revenue 185.56M
EPS 1.22
Dividend (Yield %) 1.05204
Beta 0.88
Next Earnings Date Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 1, 2023 53.68 2.87 5.65% 50.81 53.78 50.80
Nov 30, 2023 52.63 1.83 3.60% 50.80 52.72 50.80
Nov 29, 2023 52.28 0.25 0.48% 52.03 53.04 51.63
Nov 28, 2023 51.99 0.09 0.17% 51.90 53.01 50.97
Nov 27, 2023 53.25 1.10 2.11% 52.15 53.69 52.15
Nov 24, 2023 53.33 0.88 1.68% 52.45 53.56 52.20
Nov 22, 2023 53.25 1.63 3.16% 51.62 54.26 51.62
Nov 21, 2023 53.18 0.56 1.06% 52.62 53.68 51.96
Nov 20, 2023 53.71 0.65 1.23% 53.06 53.71 51.62
Nov 17, 2023 53.06 0.11 0.21% 52.95 53.18 52.22
Nov 16, 2023 52.95 0.66 1.26% 52.29 53.04 50.90
Nov 15, 2023 52.11 2.35 4.72% 49.76 52.87 49.76
Nov 14, 2023 52.01 2.32 4.67% 49.69 52.19 49.69
Nov 13, 2023 49.67 1.19 2.45% 48.48 49.90 48.48
Nov 10, 2023 48.51 1.78 3.81% 46.73 48.82 46.72
Nov 9, 2023 48.77 1.43 3.02% 47.34 49.42 47.34
Nov 8, 2023 49.32 0.36 0.74% 48.96 49.61 48.48
Nov 7, 2023 49.44 0.49 1.00% 48.95 49.69 48.95
Nov 6, 2023 49.13 1.17 2.44% 47.96 49.57 47.96
Nov 3, 2023 48.40 1.77 3.80% 46.63 48.95 46.46

LeMaitre Vascular Events

Time (UTC) Country Event
Wednesday, December 6, 2023

Time (UTC)

15:00

Country

US

Event

LeMaitre Vascular Inc at Sidoti December Virtual Small-Cap Conference
LeMaitre Vascular Inc at Sidoti December Virtual Small-Cap Conference

Forecast

-

Previous

-
Wednesday, February 21, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 LeMaitre Vascular Inc Earnings Release
Q4 2023 LeMaitre Vascular Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 161.651 154.424 129.366 117.232 105.568
Revenue 161.651 154.424 129.366 117.232 105.568
Cost of Revenue, Total 56.755 53.042 44.748 37.379 31.629
Gross Profit 104.896 101.382 84.618 79.853 73.939
Total Operating Expense 134.822 117.999 100.578 96.049 77.359
Selling/General/Admin. Expenses, Total 55.483 46.961 41.158 46.957 43.247
Research & Development 13.294 11.801 10.099 9.276 8.197
Depreciation / Amortization 6.183 6.195 5.043 2.437 1.76
Unusual Expense (Income) 3.107 0 -0.47 0 -7.474
Operating Income 26.829 36.425 28.788 21.183 28.209
Interest Income (Expense), Net Non-Operating 0.661 -2.138 -1.432 0.496 0.235
Net Income Before Taxes 27.49 34.287 27.356 21.679 28.444
Net Income After Taxes 20.636 26.907 21.22 17.934 22.543
Net Income Before Extra. Items 20.636 26.907 21.22 17.934 22.543
Net Income 20.636 26.907 21.22 17.934 22.943
Income Available to Common Excl. Extra. Items 20.636 26.907 21.22 17.934 22.543
Income Available to Common Incl. Extra. Items 20.636 26.907 21.22 17.934 22.943
Diluted Net Income 20.636 26.907 21.22 17.934 22.943
Diluted Weighted Average Shares 22.171 21.475 20.479 20.326 20.242
Diluted EPS Excluding Extraordinary Items 0.93077 1.25295 1.03618 0.88232 1.11367
Dividends per Share - Common Stock Primary Issue 0.485 0.425 0.37 0.325 0.265
Diluted Normalized EPS 1.03596 1.25295 1.01838 0.88232 0.82104
Total Extraordinary Items 0.4
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 50.115 47.075 40.954 39.028 42.108
Revenue 50.115 47.075 40.954 39.028 42.108
Cost of Revenue, Total 18.029 16.192 14.9 13.958 14.298
Gross Profit 32.086 30.883 26.054 25.07 27.81
Total Operating Expense 40.663 39.201 33.987 32.878 36.324
Selling/General/Admin. Expenses, Total 16.429 17.27 13.997 13.923 13.977
Research & Development 4.516 3.875 3.554 3.462 3.346
Depreciation / Amortization 1.509 1.559 1.536 1.535 1.596
Operating Income 9.452 7.874 6.967 6.15 5.784
Interest Income (Expense), Net Non-Operating 0.867 0.143 0.831 -0.002 -0.236
Net Income Before Taxes 10.319 8.017 7.798 6.148 5.548
Net Income After Taxes 8.098 6.04 5.627 5.456 3.515
Net Income Before Extra. Items 8.098 6.04 5.627 5.456 3.515
Net Income 8.098 6.04 5.627 5.456 3.515
Income Available to Common Excl. Extra. Items 8.098 6.04 5.627 5.456 3.515
Income Available to Common Incl. Extra. Items 8.098 6.04 5.627 5.456 3.515
Diluted Net Income 8.098 6.04 5.627 5.456 3.515
Diluted Weighted Average Shares 22.451 22.274 22.237 22.217 22.129
Diluted EPS Excluding Extraordinary Items 0.3607 0.27117 0.25305 0.24558 0.15884
Dividends per Share - Common Stock Primary Issue 0.14 0.125 0.125 0.125 0.125
Diluted Normalized EPS 0.36699 0.28148 0.25305 0.24558 0.2478
Unusual Expense (Income) 0.18 0.305 0 0 3.107
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 161.733 139.883 94.263 92.092 94.017
Cash and Short Term Investments 82.691 69.959 26.978 32.681 47.986
Cash & Equivalents 19.134 13.855 26.764 11.786 26.318
Total Receivables, Net 22.04 19.631 19.552 16.572 15.721
Accounts Receivable - Trade, Net 22.04 19.631 19.552 16.572 15.721
Total Inventory 50.271 46.104 45.115 39.527 27.388
Prepaid Expenses 6.731 4.189 2.618 3.312 2.922
Other Current Assets, Total
Total Assets 310.476 292.802 252.81 188.341 153.088
Property/Plant/Equipment, Total - Net 33.535 32.13 31.102 30.062 14.102
Property/Plant/Equipment, Total - Gross 58.659 55.061 51.187 47.834 29.446
Accumulated Depreciation, Total -25.124 -22.931 -20.085 -17.772 -15.344
Goodwill, Net 65.945 65.945 65.945 39.951 29.868
Intangibles, Net 46.527 52.71 58.905 24.893 13.692
Other Long Term Assets, Total 2.736 2.134 2.595 1.343 1.409
Total Current Liabilities 25.329 21.813 25.145 20.851 19.758
Accounts Payable 2.903 2.34 2.394 2.604 1.732
Accrued Expenses 21.404 17.651 17.085 14.768 12.368
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 1.022 1.822 3.166 3.479 5.658
Total Liabilities 42.275 38.651 80.238 40.2 22.853
Total Long Term Debt 0 0 35.532 0 0
Deferred Income Tax 0.069 0.07 0.127 1.179 0.484
Other Liabilities, Total 16.877 16.768 19.434 18.17 2.611
Total Equity 268.201 254.151 172.572 148.141 130.235
Redeemable Preferred Stock 0 0 0 0
Common Stock 0.237 0.235 0.221 0.217 0.211
Additional Paid-In Capital 189.268 181.63 114.924 105.934 98.442
Retained Earnings (Accumulated Deficit) 97.773 88.125 70.554 57.029 45.831
Treasury Stock - Common -13.046 -12.404 -11.602 -11.032 -10.349
Other Equity, Total -6.031 -3.435 -1.525 -4.007 -3.9
Total Liabilities & Shareholders’ Equity 310.476 292.802 252.81 188.341 153.088
Total Common Shares Outstanding 22.0871 21.9229 20.523 20.1569 19.6087
Short Term Investments 63.557 56.104 0.214 20.895 21.668
Current Port. of LT Debt/Capital Leases 0 2.5
Long Term Debt 0 35.532
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 182.184 174.49 164.768 161.733 153.142
Cash and Short Term Investments 97.018 90.177 81.005 82.691 79.739
Cash & Equivalents 18.051 19.488 16.677 19.134 16.913
Short Term Investments 78.967 70.689 64.328 63.557 62.826
Total Receivables, Net 23.882 26.406 25.365 22.04 20.094
Accounts Receivable - Trade, Net 23.882 26.406 25.365 22.04 20.094
Total Inventory 56.187 53.831 53.779 50.271 47.711
Prepaid Expenses 5.097 4.076 4.619 6.731 4.842
Total Assets 334.012 326.467 314.866 310.476 302.048
Property/Plant/Equipment, Total - Net 37.207 37.021 34.769 33.535 31.136
Goodwill, Net 65.945 65.945 65.945 65.945 65.945
Intangibles, Net 43.199 43.999 45.508 46.527 48.063
Other Long Term Assets, Total 5.477 5.012 3.876 2.736 3.762
Total Current Liabilities 29.029 25.855 23.904 25.329 23.439
Accounts Payable 4.371 3.519 3.371 2.903 2.848
Accrued Expenses 24.091 21.264 19.297 21.404 18.82
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total 0.567 1.072 1.236 1.022 1.771
Total Liabilities 45.375 42.64 40.701 42.275 40.801
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Deferred Income Tax 0.069 0.072 0.071 0.069 0.06
Other Liabilities, Total 16.277 16.713 16.726 16.877 17.302
Total Equity 288.637 283.827 274.165 268.201 261.247
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.239 0.239 0.238 0.237 0.236
Additional Paid-In Capital 198.254 196.941 192.003 189.268 186.798
Retained Earnings (Accumulated Deficit) 110.081 105.696 100.714 97.773 94.896
Treasury Stock - Common -13.232 -13.227 -13.218 -13.046 -12.556
Other Equity, Total -6.705 -5.822 -5.572 -6.031 -8.127
Total Liabilities & Shareholders’ Equity 334.012 326.467 314.866 310.476 302.048
Total Common Shares Outstanding 22.2632 22.2631 22.1427 22.0871 22.0009
Other Current Assets, Total 0.756
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 20.636 26.907 21.22 17.934 22.943
Cash From Operating Activities 25.378 35.102 34.8 14.179 19.506
Cash From Operating Activities 9.433 11.07 8.395 5.416 4.324
Deferred Taxes -0.182 0.079 -0.328 0.824 -2.152
Non-Cash Items 8.893 7.01 4.65 3.891 -3.96
Cash Taxes Paid 8.343 10.147 4.47 4.817 5.521
Changes in Working Capital -13.402 -9.964 0.863 -13.886 -1.649
Cash From Investing Activities -10.371 -61.076 -52.891 -24.1 -7.055
Capital Expenditures -3.229 -4.882 -2.982 -3.761 -3.054
Other Investing Cash Flow Items, Total -7.142 -56.194 -49.909 -20.339 -4.001
Cash From Financing Activities -9.234 13.702 32.155 -4.622 -4.416
Financing Cash Flow Items -1.07 -0.401 -4.551 -2.059 -1.199
Total Cash Dividends Paid -10.988 -9.336 -7.695 -6.736 -5.445
Issuance (Retirement) of Stock, Net 2.824 62.439 5.401 4.173 2.228
Foreign Exchange Effects -0.494 -0.637 0.914 0.011 -0.813
Net Change in Cash 5.279 -12.909 14.978 -14.532 7.222
Issuance (Retirement) of Debt, Net 0 -39 39
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 6.04 20.636 15.009 9.553 6.038
Cash From Operating Activities 2.279 25.378 21.301 13.959 4.711
Cash From Operating Activities 2.351 9.433 7.145 4.817 2.373
Non-Cash Items 2.001 8.893 7.093 5.191 1.265
Cash Taxes Paid -0.271 8.343 6.822 3.991 0.731
Changes in Working Capital -8.113 -13.402 -7.946 -5.602 -4.965
Cash From Investing Activities -2.964 -10.371 -9.969 -1.509 -0.536
Capital Expenditures -2.13 -3.229 -1.969 -1.509 -0.536
Other Investing Cash Flow Items, Total -0.834 -7.142 -8 0
Cash From Financing Activities -1.825 -9.234 -7.112 -4.965 -2.38
Total Cash Dividends Paid -3.099 -10.988 -8.238 -5.488 -2.743
Issuance (Retirement) of Stock, Net 1.274 2.824 1.527 0.523 0.363
Issuance (Retirement) of Debt, Net 0 0 0 0
Foreign Exchange Effects 0.053 -0.494 -1.162 -0.552 -0.09
Net Change in Cash -2.457 5.279 3.058 6.933 1.705
Financing Cash Flow Items -1.07 -0.401
Deferred Taxes -0.182
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 13.3575 2973808 31370 2023-06-30 LOW
LeMaitre (George W) Individual Investor 10.5317 2344685 -625 2023-08-23 LOW
Conestoga Capital Advisors, LLC Investment Advisor 8.6133 1917581 55895 2023-09-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.6143 1472552 7232 2023-06-30 LOW
Copeland Capital Management, LLC Investment Advisor/Hedge Fund 5.5304 1231241 5515 2023-09-30 LOW
Geneva Capital Management LLC Investment Advisor 4.0532 902362 -4610 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5052 780359 34233 2023-06-30 LOW
Ranger Investment Management, L.P. Investment Advisor 3.4866 776221 -213764 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 3.0041 668812 4905 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8902 420819 17967 2023-06-30 LOW
Congress Asset Management Company, LLP Investment Advisor 1.6759 373113 361296 2023-06-30 LOW
Russell Investments Trust Company Investment Advisor 1.3216 294223 -23338 2023-06-30 LOW
Kennedy Capital Management, Inc. Investment Advisor 1.2636 281317 -27852 2023-06-30 MED
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.2438 276905 -35214 2023-06-30 LOW
Rice Hall James & Associates, LLC Investment Advisor/Hedge Fund 1.1338 252418 -2048 2023-06-30 LOW
AWM Investment Company, Inc. Investment Advisor/Hedge Fund 1.0331 230000 0 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.8845 196920 9450 2023-06-30 LOW
Scout Investments, Inc. Investment Advisor 0.8699 193673 -5773 2023-06-30 MED
D. F. Dent & Company, Inc. Investment Advisor 0.7911 176127 -55888 2023-06-30 LOW
Parametric Portfolio Associates LLC Investment Advisor 0.7669 170742 40559 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

LeMaitre Vascular Company profile

About LeMaitre Vascular Inc

LeMaitre Vascular, Inc. is a medical device company. The Company provides medical devices and human tissue cryopreservation services used in the treatment of peripheral vascular disease, end-stage renal disease and cardiovascular disease. It develops, manufactures and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. Its portfolio of devices consists of products that are used in arteries and veins outside of the heart, which includes the LeMaitre valvulotome, the XenoSure biologic patch, the Artegraft collagen vascular graft, the Pruitt F3 carotid shunt, VascuTape radiopaque tape and Syntel embolectomy catheters. Its product line includes Valvulotomes, Surgical Glue, Remote Endarterectomy Devices, Radiopaque Tape, Powered Phlebectomy, ePTFE Vascular Grafts, Polyester Vascular Grafts, Ovine Vascular Grafts, Closure Systems, Carotid Shunts, Allografts, Angioscopes and many others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, LeMaitre Vascular Inc revenues increased 19% to $154.4M. Net income increased 27% to $26.9M. Revenues reflect United States segment increase of 25% to $93.9M, Other countries segment increase of 14% to $47.6M. Net income benefited from Foreign currency loss decrease of 65% to $116K (expense). Dividend per share increased from $0.37 to $0.43.

Equity composition

Common Stock $.01 Par, 03/11, 100M auth., 16,144,485 issd., less 639,155 shs. in Treas. @ $3.8M. Insiders control 36.71%. IPO: 10/06,5.5M shs. @ $7 per share by Goldman, Sachs & Co., CIBC Worlds Markets, Cowen & Co. and Thomas Weisel Partners LLC. Pref. Stock $.01 Par, 5M auth.,none issued.

Industry: Advanced Medical Equipment & Technology (NEC)

63 2nd Ave
BURLINGTON
MASSACHUSETTS 01803
US

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

Oil - Crude

74.50 Price
-1.560% 1D Chg, %
Long position overnight fee -0.0136%
Short position overnight fee -0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.040

Gold

2,072.25 Price
+1.760% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 22:00 (UTC)
Spread 0.30

US100

16,001.20 Price
+0.470% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

0.62 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading